Canada· CA-DIN-00783668
GLYCEROLYTE 57 SOLUTION
A blood transfusion, auxiliary products product containing sodium lactate + potassium chloride + sodium phosphate dibasic + sodium phosphate monobasic, registered in Canada by FRESENIUS KABI AG. The same ATC class is registered in 2 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Sodium lactate + potassium chloride + sodium phosphate dibasic + sodium phosphate monobasic is registered in 2 of 19 countries.
Countries holding a registration under ATC V07AC (blood transfusion, auxiliary products), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 1 of them publish a price we can compare per daily dose
Sodium lactate + potassium chloride + sodium phosphate dibasic + sodium phosphate monobasic · ATC V07AC
2 / 19 countries
- Canada
- Czechiaprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- SODIUM LACTATE + POTASSIUM CHLORIDE + SODIUM PHOSPHATE DIBASIC + SODIUM PHOSPHATE MONOBASIC
- Manufacturer
- FRESENIUS KABI AG
- Country
- Canada (CA)
- ATC code
- V07AC
- ATC class
- Blood transfusion, auxiliary products
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V07AC
Blood transfusion, auxiliary products, as other registers publish it.
- Canada12% SODIUM CHLORDIE PROCESSING SOLUTIONBAXTER CORPORATION
- CanadaADDITIVE SOLUTION FORMULA 3 AS-3TERUMO BCT, INC.
- CanadaADDITIVE SOLUTION SODIUM ADENINE GLUCOSE MANNITOL (SAGM)MACO PHARMA
- CanadaANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA AFRESENIUS KABI AG
- CanadaANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA ATERUMO BCT, INC.
- CanadaANTICOAGULANT SOD CITRATE SOLTN 4GM/100MLBAXTER CORPORATION
- CanadaANTICOAGULANT SODIUM CITRATE 4% W/V SOLUTION, USPBAXTER CORPORATION
- CanadaANTICOAGULANT SODIUM CITRATE SOLUTION, USPFRESENIUS KABI CANADA LTD
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cbcc3a4e-2ef6-4301-91e4-6d8e5e18b893 GET /v1/drugs/cbcc3a4e-2ef6-4301-91e4-6d8e5e18b893?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "00783668",
"form": "SOLUTION",
"class": "Human",
"routes": [
"0-UNASSIGNED"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "V07AC",
"schedule": [
"Ethical"
],
"drug_code": "11330",
"strengths": [
"1.6 G",
"30 MG",
"124.2 MG",
"51.7 MG",
"57 G"
],
"ahfs_class": null,
"substances": [
"SODIUM LACTATE",
"POTASSIUM CHLORIDE",
"SODIUM PHOSPHATE DIBASIC",
"SODIUM PHOSPHATE MONOBASIC",
"GLYCERINE"
],
"product_categorization": null
}See everything about sodium lactate + potassium chloride + sodium phosphate dibasic + sodium phosphate monobasic.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.